Skip to main content
. Author manuscript; available in PMC: 2012 Mar 7.
Published in final edited form as: J Immunol Methods. 2011 Jan 19;366(1-2):43–51. doi: 10.1016/j.jim.2011.01.002

Table 1.

HLA types of HC/2G-1 sensitive tumors:

HLA-A HLA-B HLA-C HLA-DRβ1* HLA-DR β HLA-DQ
RCC#1 01; 02 08; 40 03; 07 03; 04 3*00; 4*01
RCC#6 31 35 03; 04 08; 14 3*01 03; 04
RCC#7 02; 25 44 05 04; 12 3*02; 4*01 03; 03
RCC#8 02; 03 08; 35 07 03; 07 3*01; 4*01 02; 03
RCC#10 02; 24 44; 51 05; 15 04; 12 3*01; 4*01 02; 03
MDA231 02 40; 41 02; 17 07; 13 3*02; 4*01 02; 03
MDA386 01 08 07 03 3*01 02
H2087 02 44 16
HHS Vulnerability Disclosure